| 1. |
Luiz Pereira de Magalhäes, Marcio Jansen de Oliveira Figueiredo, Fatima Dumas Cintra, et al. Executive summary of the Ⅱ Brazilian guidelines for atrial fibrillation. Arq Bras Cardiol, 2016, 107(6): 501-508.
|
| 2. |
Zoni-Berisso M, Lercari F, Carazza T, et al. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol, 2014, 6: 213-220.
|
| 3. |
Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation, 2003, 107(23): 2920-2925.
|
| 4. |
Lubitz SA, Yin X, Fontes JD, et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA, 2010, 304(20): 2263-2269.
|
| 5. |
Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest, 2010, 137(2): 263-272.
|
| 6. |
Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med, 2001, 344(14): 1043-1051.
|
| 7. |
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 2014, 130(23): 2071-2104.
|
| 8. |
Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA, 2014, 311(7): 692-700.
|
| 9. |
Rotter M, Takahashi Y, Sanders P, et al. Reductionof fluoroscopy exposure and procedure duration during ablation of atrial fibrillation using a novel anatomical navigation system. Eur Heart J, 2005, 26(14): 1415-1421.
|
| 10. |
Cox JL. Cardiac surgery for arrhythmias. J Cardiovasc Electrophysiol, 2004, 15(2): 250-262.
|
| 11. |
Cox JL, Ad N, Palazzo T, et al. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg, 2000, 12(1): 15-19.
|
| 12. |
Gelsomino S, Van Breugel HN, Pison L, et al. Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation. Eur J Cardiothorac Surg, 2014, 45(3): 401-407.
|
| 13. |
La Meir M. Surgical options for treatment of atrial fibrillation. Ann Cardiothorac Surg, 2014, 3(1): 30-37.
|
| 14. |
Kurfirst V, Mokrácek A, Bulava A, et al. Two-staged hybrid treatment of persistent atrial fibrillation: short-term single centre results. Interact Cardiovasc Thorac Surg, 2014, 18(4): 451-456.
|
| 15. |
Badhwar V, Rankin JS, Damiano RJ Jr, et al. The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg, 2017, 103(1): 329-341.
|
